[Results of the treatment of superficial hyperkeratotic lesions with Solcoderm].
D000085:Acetates / Q000627:therapeutic use; D019342:Acetic Acid; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D002986:Clinical Trials as Topic; D003300:Copper / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use*; D007642:Keratosis / Q000188:drug therapy* / Q000209:etiology; D007773:Lactates / Q000627:therapeutic use; D009566:Nitrates / Q000627:therapeutic use
D000085:Acetates; D003879:Dermatologic Agents; D007641:Keratolytic Agents; D007773:Lactates; D009566:Nitrates; D003300:Copper; D019342:Acetic Acid
Ocena wyników leczenia powierzchownych zmian hiperkeratotycznych preparatem Solcoderm.